Attached files
| file | filename |
|---|---|
| EX-3.2 - EX-3.2 - ALNYLAM PHARMACEUTICALS, INC. | d19384dex32.htm |
| EX-3.1 - EX-3.1 - ALNYLAM PHARMACEUTICALS, INC. | d19384dex31.htm |
| EX-23.1 - EX-23.1 - ALNYLAM PHARMACEUTICALS, INC. | d19384dex231.htm |
| EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC. | d19384dex311.htm |
| EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC. | d19384dex312.htm |
| EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC. | d19384dex321.htm |
| EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC. | d19384dex322.htm |
| 10-K - FORM 10-K - ALNYLAM PHARMACEUTICALS, INC. | d19384d10k.htm |
| EX-10.12 - EX-10.12 - ALNYLAM PHARMACEUTICALS, INC. | d19384dex1012.htm |
EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
| Name |
Ownership Percentage | Jurisdiction of Organization | ||
| Alnylam U.S., Inc. | 100% | Delaware | ||
| Alnylam Europe AG | 100% | Germany | ||
| Alnylam Securities Corporation | 100% | Massachusetts | ||
| Alnylam (Bermuda) Ltd. | 100% | Bermuda | ||
| Alnylam UK Limited | 100% | United Kingdom | ||
| Alnylam Switzerland GmbH | 100% | Switzerland | ||
| Sirna Therapeutics, Inc. | 100% | Delaware |